 iHerb | $ 29.69 | |
| iHerb | $ 29.69 | |
 Amazon | $ 29.69 |
Astaxanthin supports broad antioxidant protection, while zeaxanthin is concentrated in the macula and gives the formula a stronger eye-health purpose. The 4 mg amount of each carotenoid is clearly stated.
A softgel is a sensible format for fat-soluble carotenoids, but the carrier oil and stability features are absent from the supplied data. The biological source of astaxanthin is also unclear.
The serving value is fair for a specialized two-active combination. It fits people who want a compact eye formula rather than a high-dose standalone astaxanthin product.
Branded zeaxanthin adds quality, but the astaxanthin source and standardization are not identified; both carotenoids have meaningful amounts for a combined eye formula. The astaxanthin amount is within a commonly used supplemental range; astaxanthin and zeaxanthin fit antioxidant and vision support well; the focused formula contains no low-value active additions.
Listed actives generally have specific amounts; no proprietary blend hides key doses except where noted. Zeaxanthin is specifically branded, while the astaxanthin source and carrier system remain unclear; serving directions and inactive ingredients are not supplied.
.The supplied aggregate average is favorable, though no individual feedback is available; the large rating sample improves confidence in the aggregate average, but no individual feedback is supplied. Detailed feedback is absent, so repeated complaints cannot be assessed; real-world fit with the intended purpose remains uncertain.
.Two useful carotenoids support good formula value; the serving cost is reasonable for the active amounts. The focused formula contains no low-value active additions; the formula is competitively positioned among basic eye carotenoid products.
.
Astaxanthin and zeaxanthin directly support retinal antioxidant defense and macular light filtering. Both carotenoids have relevant human evidence, with stronger long-term vision support established for macular pigments.
Four milligrams of each carotenoid provides meaningful combined exposure. The pairing is complementary and logically focused on vision.
Astaxanthin and zeaxanthin provide complementary antioxidant and eye-tissue support. Both carotenoids are supplied at meaningful amounts, although the astaxanthin source is not identified.
The softgel may aid absorption while missing carrier details limit certainty. The formula is coherent for visual and oxidative aging but does not cover broader mitochondrial or structural needs.
Astaxanthin and zeaxanthin provide complementary carotenoid antioxidant activity that may help limit oxidative stress linked with inflammation. The astaxanthin amount is meaningful, while zeaxanthin contributes mainly to the same antioxidant pathway.
The softgel suits these fat-soluble compounds and both amounts are transparent. The astaxanthin source and carrier oil are not identified, which limits confidence in ingredient quality and delivery.
Astaxanthin directly supports antioxidant defense and may improve skin resilience to ultraviolet stress. Human trials also suggest benefits for moisture, elasticity, and skin texture at commonly used amounts.
The 4 mg amount is clearly disclosed and lies within a clinically used range. The biological astaxanthin source is not named, and carrier-oil and stability details are absent. Lutein and zeaxanthin mainly broaden eye support rather than adding distinct skin pathways.
Astaxanthin can reach brain tissue and may help protect neurons from oxidative stress, which supports long-term cognitive resilience. Direct evidence for improving memory, attention, or processing speed is limited compared with established cognitive actives.
The 4 mg serving is clinically relevant, and the active yield is clear but the algal source is not identified. The softgel suits a fat-soluble carotenoid, although carrier oil and oxidation-protection details are not fully disclosed.
Astaxanthin may support antioxidant and inflammation-related pathways relevant to joint comfort. Zeaxanthin adds antioxidant activity but has little direct joint evidence.
The astaxanthin amount is practical and the softgel may aid absorption. The formula does not provide cartilage building blocks or joint lubrication.
Astaxanthin and zeaxanthin provide antioxidant protection but are more directly suited to eye health. Neither carotenoid has a strong role in lipid management, vascular tone, or cardiac energy.
The disclosed amounts are useful for carotenoid support without forming a complete heart formula. No established cardiovascular active broadens the pathway coverage.
| Ingredient | Amount per serving |
|---|---|
Astaxanthin | 4 mg |
OmniXan Zeaxanthin | 4 mg |
The 4 mg serving provides a clinically relevant astaxanthin amount and clearly states the active yield. A softgel may support absorption, but no algal source, carrier oil, branded material, stabilizer, or protective packaging is identified. Cost efficiency falls within the fair market range for the delivered amount.
Published studies used for the product analysis and the top-ranked studies for each ingredient and goal.
